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A B S T R A C T
To exert their therapeutic action, probiotic Saccharomyces cerevisiae strains must survive harsh
digestive environments. Lipid droplets accumulate in cells which undergo stress-inducing
situations, supposedly having a protective role.We assessed lipid droplet levels, either natu-
rally accumulated or induced in response to digestive challenges, of probiotic strains S. boulardii,
S. cerevisiaeA-905, S. cerevisiae Sc47 and S. cerevisiae L11, and of non-probiotic strains S. cerevisiae
BY4741 and S. cerevisiae BY4743. Strains 905 and Sc47 had lower and higher lipid droplet levels,
respectively, when compared to the remaining strains, showing that higher accumulation
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of these neutral lipids is not a feature shared by all probiotic Saccharomyces strains. When submitted to
simulated gastric or bile salts environments, lipid droplet levels increase in all tested probiotic strains, at
least for one to the induced stresses, suggesting that lipid droplets participate in the protective mechanisms
against gastrointestinal stresses in probiotic Saccharomyces yeasts.
© 2015 Elsevier Ltd. All rights reserved.
1. Introduction
Lipid droplets (LD), the fat reservoirs of eukaryotic cells, are
composed mostly of triacylglycerols (TAG) and sterol esters
(SE), and are involved in many biological processes, such as
inflammation, immune response, antigen presentation and
interactions with pathogens (Saka & Valdivia, 2012). These
intracellular organelles play a role in the lipid homeostasis
and tend to increase when cells undergo stress situations,
such as endoplasmic reticulum, oxidative and osmotic stresses
(Khor, Shen, & Kraemer, 2013), protecting the cell against the
effects of misfolded proteins and toxic lipids (Hapala, Marza,
& Ferreira, 2011). In Saccharomyces cerevisiae, LD levels have
been shown to increase when yeasts are subjected to tem-
perature and secretory stresses (Fei, Wang, Fu, Bielby, & Yang,
2009; Gaspar et al., 2008; Hapala et al., 2011), drug treatment
(Garaiová, Zambojová, Šimová, Griacˇ, & Hapala, 2014) and to
high saline concentrations and nitrogen starvation (Madeira
et al., 2014).
Some S. cerevisiae strains have probiotic properties, which
can provide health benefits to human [and animal] hosts
when administered in adequate amounts (Vieira, Teixeira, &
Martins, 2013). To date, S. cerevisiae var. boulardii (henceforth
designed as S. boulardii) is the only probiotic yeast approved
by the FDA for human consumption (Czerucka, Piche, & Rampal,
2007), although several S. cerevisiae strains have proven probiotic
potential (Diosma, Romanin, Rey-Burusco, Londero, & Garrote,
2014; Kourelis et al., 2010; Martins et al., 2005; Palma et al.,
2015; Perricone, Bevilacqua, Corbo, & Sinigaglia, 2014; Van
der Aa Kühle, Skovgaard, & Jespersen, 2005) and some are
commercialised as animal feed additives and veterinary
probiotics (Ferraretto, Shaver, & Bertics, 2012; Pérez-Sotelo
et al., 2005; Zanello et al., 2013). Probiotic S. cerevisiae
strains are used as therapeutics against several types of
diarrhoea, colitis and other gastrointestinal tract (GIT)
malaises (Czerucka et al., 2007). To exert their probiotic po-
tential, these yeasts must survive the harsh environments of
the GIT, such as gastric acidic pH, bile salts and intestinal
proteases (Fietto et al., 2004). It has been proposed that
S. boulardii resistance to GIT milieus is related with
overexpression of genes related to stress responses
(Edwards-Ingram et al., 2007). However, the mechanisms re-
sponsible for probiotic S. cerevisiae survival in the GIT are still
scarcely unknown. In this work, due to the cellular protective
role of LD against several stress conditions, we sought to
investigate if these organelles also play a protective role in
probiotic S. cerevisiae yeasts when these are submitted to di-
gestive challenges.
2. Materials and methods
2.1. Reagents, strains and growth media
All reagents, unless specified otherwise, were purchased from
Sigma-Aldrich (St. Louis, MO, USA).
S. cerevisiae strains used in this work are listed in Table 1.
Yeasts were manipulated as previously described (Douradinha
et al., 2014; Madeira et al., 2014; Martins et al., 2005) and grown
in YPD medium (1% yeast extract, 2% peptone, 2% dextrose)
at either 37 °C (probiotics) or 30 °C (non-probiotics). Follow-
ing overnight growth, yeasts were diluted to the desired working
optical density at 600 nm (OD600).
2.2. Doubling time
To determine yeast doubling time, cells were diluted to an OD600
of 0.2 and grown in YPD at the referred temperatures and in-
cubated in a Bioscreen C spectrophotometer (Growth Curves,
Piscataway, NJ, USA), according to manufacturer’s instruc-
tions, during 28 h. The OD600 was measured every 15 min. All
strains reached stationary phase by 24 h (Fig. S1). Doubling time
was calculated based on the OD600 values of early to mid-log
phase with GraphPad Prism 5.0 (GraphPad Software, La Jolla,
CA, USA) (Table S1).
Table 1 – Saccharomyces strains used in this work.
Strains Origin Supplier Reference
Probiotics
S. boulardii 17 Floratil® Merck SA (Rio de
Janeiro, Brazil)
(Blehaut
et al., 1989)
S. cerevisiae
UFMG A-905
Cachaçaa UFMGb (Belo
Horizonte, Brazil)
(Martins
et al., 2005)
S. cerevisiae Sc47 Biosaf Lesaffre Brazil
(Penha, Brazil)
(Pérez-Sotelo
et al., 2005)
S. cerevisiae L11 Procreatin7 Lesaffre Brazil
(Penha, Brazil)
(Ferraretto
et al., 2012)
Non-probiotics
S. cerevisiae
BY4741
– Open Biosystems
(Lafayette, CO)
(Winston
et al., 1995)
S. cerevisiae
BY4743
– ATCC (Manassas,
VA)
(Brachmann
et al., 1998)
a Brazilian alcoholic spirit drink derived from sugarcane fermentation.
b Universidade Federal de Minas Gerais.
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2.3. Lipid droplets quantification using liquid
fluorescence recovery assay (LFR)
LD were quantified by LFR as previously described
(Bozaquel-Morais, Madeira, Maya-Monteiro, Masuda, &
Montero-Lomeli, 2010). Briefly, cells were grown for 24 h,washed
in distilled water and aliquoted to an OD600 of 5.0. Cells were
subsequently fixed with 3.7% formaldehyde. Cells were washed
and then diluted in reading medium, which contains 5 µM of
the neutral lipid probe BODIPY 493/503 (LifeTechnologies, Grand
Island, NY, USA) and 500 µM of fluorescence quencher KI. Ab-
sorbance at 600 nm (A600) and fluorescence recovery by cell
addition at 495/510 were read in a SpectraMax M5 plate reader
(Molecular Devices, Sunnyvale, CA, USA). The cellular neutral
lipid content (LDindex) was determined as the ratio fluores-
cence intensity/cellular density (A600).
2.4. Lipid droplets quantification using flow cytometry
Yeast cells were fixed and labelled with BODIPY as described
above. Samples were acquired on an LSRII flow cytometer (BD
Biosciences, Franklin Lakes, NJ, USA) and excited with the
488 nm laser. The mean fluorescence intensity (MFI) was de-
termined in the singlet population of yeast cells and data were
analysed using FlowJo software (FlowJo LLC, Ashland, OR, USA)
and GraphPad Prism.The different strains tested varied in size,
as shown by their respective forward scatter (FSC) param-
eter. LD content was determined by normalising each strain
MFI with its respective size proportion to S. cerevisiae BY4741
(Fig. S2).
2.5. Lipid droplets quantification using confocal
fluorescence microscopy
LD number and area were quantified by fluorescence micros-
copy as described elsewhere (Bozaquel-Morais et al., 2010;
Madeira et al., 2014). Cells were fixed and treated with BODIPY
as above and images acquired in an Axio Observer Z1 micro-
scope (Zeiss, Göttingen, Germany). Images were processed with
Zen 2012 software (Zeiss). LD number and area were quanti-
fied in 200 cells per strain using ImageJ software (NIH, Bethesda,
MD, USA).
2.6. Thin layer chromatography (TLC)
Yeast cells were centrifuged at 1500 g, washed once with water,
heat dried and weighed. Lipids were extracted of 320 µg of each
yeast sample as previously described (Bourque & Titorenko,
2009; Madeira et al., 2014), allowed to dry, redissolved in chlo-
roform and resolved by two-dimensional TLC (Madeira et al.,
2014; Schmidt, Ploier, Koch, & Daum, 2013). Lipids were de-
veloped using iodine vapour and spots quantified by
densitometry using Image Master TotalLab 1.1 (TotalLab Ltd,
Newcastle Upon Tyne, UK).
2.7. Yeast survival in vivo
The levels of yeast survival in vivo were quantified as de-
scribed elsewhere (Martins, Veloso, Arantes, & Nicoli, 2009).
Briefly, 108 viable yeasts were administered orally to female
BALB/c mice (8–10 weeks) daily, during 10 days. On the last day,
faeces were collected, submitted to serial dilutions in sterile
PBS and plated on Sabouraud dextrose agar (Difco, São Paulo,
SP, Brazil) supplemented with chloramphenicol (200 mg/L), at
the yeasts canonical temperatures. Colony-forming units (CFU)
were assessed after 48–72 h (Fig. S3A).
Mice were provided by the Universidade Federal de Minas
Gerais (UFMG) Animal House (Belo Horizonte, MG, Brazil). All
procedures were done following the Brazilian College for Animal
Experimentation requirements,which follow the European stan-
dards for animal experiments (EU Directive 2010/63/EU). The
study was approved by the UFMG Ethics Committee in Animal
Experimentation (CETEA/UFMG, protocol no. 197/2007).
2.8. Simulated GIT stresses
Simulated GIT stresses were performed as described else-
where (Fietto et al., 2004). Briefly, yeast cells were grown
overnight and diluted to a final OD600 of 0.3, either in YPD
(control), YPD 0.1% pancreatin (Thermo Fisher,Waltham, MA,
USA) and 0.5% NaCl pH 8.0 (intestinal stress) or YPD 0.1%
mixture of primary and secondary bile salts (biliary stress). For
gastric stress, yeasts were diluted to the same final OD600 in
water 2% dextrose (control) and in gastric juice pH 1.5 (Thermo
Fisher) 2% dextrose. Following 1 h incubation, samples were
collected to assess their viability and LD levels. For the viabil-
ity assays, serial dilutions of each of the aforementioned
conditions were plated onto YPD agar plates, allowed to grow
for at least 24 h and the number of CFU quantified (Fig. S3B).
To determine lipid content, cells were washed once with water,
fixed and labelled with BODIPY as before and analysed by flow
cytometry as described above.
2.9. Statistical analysis
Statistical analyses were performed using GraphPad Prism 5.0.
Results were considered significant if, upon applying Stu-
dent’s paired, two-tailed t-test, p values were inferior to 0.05.
3. Results
3.1. LD levels accumulated heterogeneously in different
S. cerevisiae strains
It has been previously shown that the peak of accumulation
of LD in S. cerevisiae strains occurs at early stationary phase,
around 24 hours after inoculation (Bozaquel-Morais et al., 2010;
Kurat et al., 2006; Zanghellini et al., 2008). First, we confirmed
that all the tested yeasts do reach the early stationary phase
around this time-point (Fig. S1), as their doubling times are dif-
ferent (Table S1). Subsequently, to determine if the probiotic
S. cerevisiae strains accumulate higher level of LD than the labo-
ratorial non-probiotic strain S. cerevisiae BY4741 (BY4741), we
assessed the neutral lipid levels by LFR assay (Fig. 1A). Inter-
estingly, the LD levels varied greatly between strains. We
observed that veterinary probiotic S. cerevisiae Sc47 (Sc47) had
the highest LD content while S. cerevisiae A-905 (905) showed
the lowest LD levels.The other tested yeasts, S. boulardii 17 (Sb)
195J o u rna l o f Func t i ona l F ood s 2 1 ( 2 0 1 6 ) 1 9 3 – 2 0 0
and S. cerevisiae L11 (L11), did not present significant differ-
ent LD levels when compared to the non-probiotic strain. To
confirm these results, we quantified LD using flow cytometry
(Fig. 1B), observing the same pattern in yeast lipid content. Since
all probiotic strains tested were diploid while BY4741 was
haploid, we decided to also quantify LD in a non-probiotic
diploid strain, S. cerevisiae BY4743 (BY4743), to verify if their
ploidy would be related with the LD level variations observed
among the different strains studied.Assessment of BY4743 lipid
content by flow cytometry did not differ significantly when com-
pared to the haploid strain (Fig. 1B).
3.2. LD numbers, areas and composition differed among
the different yeast strains tested
Next, using fluorescence microscopy, we quantified the number
of LD per cell in each strain. Unsurprisingly, Sc47 and 905 had
the highest and lowest numbers of cellular LD, respectively,
among the tested strains (Fig. 2A). LD area did not vary between
yeasts, except for Sc47, which showed a significantly larger area
of these organelles per cell (Fig. 2B and C).
LD are mainly constituted of SE and TAG (Saka & Valdivia,
2012), so we decided to assess LD composition by thin layer
chromatography in these strains. Levels of TAG and SE were
found to be equally proportional within all tested yeasts, except
for 905, which presented very low amounts of SE (Fig. 2D).
3.3. LD level alterations in S. cerevisiae yeasts
submitted to GIT stresses were strain-specific and differed
according to the type of stress induced
Our results showed that LD levels varied heterogeneously in
different S. cerevisiae strains which had reached the station-
ary growth phase.We next addressed the question if LD levels
would increase when these strains are submitted to gastro-
intestinal stresses. Our preliminary results in BALB/c mice
showed that probiotic strains had a better colonic survival rate
than BY4741, following oral administration (Fig. S3A).Also, while
all yeasts survived and grew well in simulated intestinal con-
ditions (data not shown), growth levels during simulated gastric
and bile salts conditions indicated very different survival rates
between the several studied strains (Fig. S3B). We also as-
sessed the LD levels by flow cytometry during simulated GIT
stresses to confirm if they would increase, when compared with
the respective untreated control. As expected, no variation of
LD levels was observed when the strains were subjected to in-
testinal conditions (data not shown). However, the neutral lipid
content increased in all strains after enduring the gastric en-
vironment, except for Sb and BY4743 (Fig. 3A). The presence
of bile salts caused LD levels to remain unaltered in 905 and
BY4743 but increased in the remaining tested strains (Fig. 3B).
4. Discussion
Probiotic microorganisms must survive the GIT adverse con-
ditions so they can exert their therapeutic effect in the colon.
Although resistance to GIT challenges is one of the first con-
ditions tested in potential probiotic Saccharomyces strains (Palma
et al., 2015), very few studies have so far investigated which
potential mechanisms are responsible for the yeasts survival
in such environments (Cascio et al., 2013; Sant’Ana et al., 2009;
Edwards-Ingram et al., 2007). As mentioned before, it has been
shown that LD levels increased in S. cerevisiae undergoing situ-
ations of cellular stress (Fei et al., 2009; Garaiová et al., 2014;
Gaspar et al., 2008; Hapala et al., 2011; Madeira et al., 2014).
However, no study has yet focused on LD behaviour of
S. cerevisiae strains submitted to GIT harsh environments and
the potential contribution of these organelles in yeast sur-
vival in such aggressive conditions. In this work, we assessed
the levels of LD in probiotic and non-probiotic S. cerevisiae
strains, either when they reached stationary phase or follow-
ing simulated GIT harsh environment treatments. To the best
of our knowledge, this is the first time LD are studied in
probiotic S. cerevisiae strains.
Our first assumption was that S. cerevisiae strains with
probiotic potential naturally accumulate higher levels of neutral
lipids, which would help them to endure the severe GITmilieus.
However, our results showed that LD levels and numbers were
heterogeneous among probiotic and non-probiotic strains
Fig. 1 – Lipid droplet levels varied among different
Saccharomyces strains. LD content was quantified by
(A) liquid recovery fluorescence and (B) flow cytometry. In
both techniques, results are presented in proportion to the
lipid content of BY4741. Strains 905 and Sc47 displayed
lipid droplet levels significantly lower and higher,
respectively, when compared to those of the haploid strain.
No alterations in these organelle levels were observed in
Sb, L11 and BY4743. Data shown derived from 3
independent experiments. For each strain, LD levels
average of the 3 experiments ± standard deviation is
plotted. * and ** correspond to P < 0.05 and P < 0.01,
respectively.
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(Figs. 1 and 2A–C), suggesting that probiotic S. cerevisiae strains
resistance to GIT harsh environments is unrelated with their
initial neutral lipid accumulation levels. Interestingly, we ob-
served that one of the studied probiotic strains, 905, possesses
very low amounts of SE (Fig. 2D), which may account for the
lower LD number and levels in this strain (Figs. 1 and 2A–C).
LD composed mostly of TAG have been observed in S. cerevisiae
W303 (W303) mutants unable to produce SE (Czabany et al.,
2008). Since TAG occupies most of the LD inner core, it may
explain why LD in 905, despite their low levels, did not exhibit
smaller areas when matched to those of BY4741. Also, of all
tested strains, 905 was the most resistant to gastric and bile
salts simulated stresses (Fig. S3B). Repression of SE synthesis
is related with resistance to high saline concentrations and oxi-
dative stress in BY4741 (Montañés, Pascual-Ahuir, & Proft, 2011).
In an acidic milieu, the expression of sterol esterase, an enzyme
involved in SE biosynthesis, is downregulated in Sb (Cascio et al.,
2013), a mechanism which probably contributes to its gastric
stress resistance (Fig. S3B). Correspondingly, 905’s natural in-
ability to synthetise SE might render this yeast more resistance
to the harsh GIT environments. Sc47 is a veterinary probiotic
and feed additive used widely for fattening of pigs, cattle, rabbits
and lambs (FEEDAP, 2012). Its effectiveness as a veterinary fat-
tening agent is justified by its high lipid levels (Figs. 1 and 2A–C).
L11 is another veterinary probiotic, usually recommended to
increase milk quality and quantity in lactating animals
(Ferraretto et al., 2012), with lipid levels similar to those of Sb
and BY4741 (Figs. 1 and 2A–C). Both Sc47 and L11 survived
poorly in simulated gastric and bile salts conditions (Fig. S3B),
regardless of their lipid content levels. Animals have milder
gastric pH and bile salts concentrations than humans (Martinez,
Augsburger, Johnston, &Warren, 2002) and the conditions used
in this work mimic those of the human GIT (Fietto et al., 2004),
which explains why these probiotic strains are, nevertheless,
effective in veterinary applications. Furthermore, our tests were
done using yeasts in solution, while these animal probiotics
are supplied to animals as dried particles (FEEDAP, 2012;
Ferraretto et al., 2012), in which the outer layers of yeast protect
the inner core from the aggressive GIT conditions, a feature
similar to encapsulation in Sb (Graff, Chaumeil, Boy, Lai-Kuen,
& Charrueau, 2008). Our preliminary results showed that these
veterinary probiotic strains, when administered to BALB/c mice,
had a higher survival rate than BY4741 (Fig. S3A). Also, their
low doubling time (Table S1) would allow a faster recovery in
Fig. 2 – Lipid droplet numbers, areas and composition differed between the tested Saccharomyces strains. (A) Number of
lipid droplets per yeast was determined by fluorescence microscopy and reflected what was observed above for the neutral
lipids content, with similar variations for 905 and Sc47 when compared with BY4741. Sb, L11 and BY4743 displayed lipid
droplet numbers per cell analogous to those of BY4741. (B) Area of lipid droplets was also quantified by fluorescence
microscopy. On average, the area of these organelles did not differ in the tested strains, except for Sc47, which possessed
larger lipid droplets. Values were normalised based on BY4741 lipid droplets area per cell (C) Fluorescence pictures of
neutral lipids labelled with BODIPY (green) in the Saccharomyces strains studied. Bar, 10 µm. (D) Lipid droplet composition as
determined by thin layer chromatography. Levels of triacylglycerols (TAG) and sterols (SE) were equally proportional within
all tested yeasts, exception made for 905, which contained very low amounts of SE. Data shown derived from 3
independent experiments. For each strain, the average of (A) LD numbers, (B) LD areas and (D) ratio SE/TAG of the 3
experiments ± standard deviation is plotted. * corresponds to P < 0.05.
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the GIT than the other probiotic strains used in this work, con-
tributing to their effective probiotic action.
As previously shown, neutral lipid levels tend to increase
in S. cerevisiae strains undergoing stressful events (Fei et al., 2009;
Garaiová et al., 2014; Gaspar et al., 2008; Hapala et al., 2011;
Khor et al., 2013; Madeira et al., 2014) and, since initial LD levels
in probiotic yeasts did not relate with their resistance to GIT
challenges, we decided to quantify these neutral lipids in the
studied strains after submitting them to GIT simulated stresses.
We observed that Sb and BY4743 LD levels remained un-
changed following gastric acidic pH treatment (Fig. 3A). Sb
possesses an efficient H+-efflux system,which allows this yeast
to maintain its intracellular pH at neutral levels and contrib-
ute to its survival in acidic conditions (Sant’Ana et al., 2009).
Plus, Sb differentially regulates genes related with stress re-
sponse in low pH conditions (Cascio et al., 2013). These
combinedmechanisms seem to be sufficient to promote Sb sur-
vival in gastric conditions, suggesting that increasing LD levels
in this situation would be redundant and lead to an unrequired
consumption of cellular metabolic energy. Our results lead to
believe that BY4743 survival in acidic pH levels relies upon
similar mechanisms. It is currently unknown if the other
S. cerevisiae strains tested share these protective mecha-
nisms. A laboratorial strain, W303, displayed low H+-ATPase
activity, rendering it much more sensitive to acidic pH levels
(Sant’Ana et al., 2009).We assume that the remaining strains
used in this work have a weak proton efflux capacity similar
to W303, although that remains to be confirmed. The ob-
served increase in LD levels in these S. cerevisiae strains following
gastric juice treatment (Fig. 3A) would compensate as a pro-
tective mechanism and allow them to resist acidic stress.
Resistance to bile salts induced stress also varied in the
tested strains (Fig. 3B and Fig. S3B). Thus, it is not surprising
that exposure to a biliary environment would lead the least
resistant strains into stress and consequently to the increase
observed in their neutral lipid levels (Fig. 3B), suggesting they
use an LD-based protective mechanismwhen submitted to this
particular GIT stress. Both 905 and BY4743 strains did not show
4741 Sb 905 Sc47 L11 4743
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Fig. 3 – Influence of simulated (A) gastric and (B) bile salts stresses in Saccharomyces strains LD levels. Yeast neutral lipid
levels content was measured by cytometry after 1 h of treatment with gastric juice or bile salts and matched to
corresponding untreated controls. All probiotic yeasts had higher levels of LD in at least one harsh condition studied,
suggesting these organelles played a protective role when these strains are submitted to GIT stresses. Likewise, neutral
lipids increased in BY4741 in both low pH and bile salts conditions indicating a similar type of protection as for the
probiotic strains. On the other hand, BY4743 LD levels remained unchanged in both stresses, suggesting that this strain in
particular possessed other mechanisms to resist the GIT harsh environments. Data shown derived from 3 independent
experiments. For each strain, the average of MFI for both untreated and stress-submitted conditions of the 3
experiments ± standard deviation is plotted.* and ** correspond to P < 0.05 and P < 0.01, respectively.
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an increment in their LD levels, indicating they depend on other
mechanisms to survive bile salts action (Fig. 3B and Fig. S3B).
Our work addressed, for the first time, the issue of LD in
probiotic microorganisms and their participation in protec-
tion against GIT stresses, contributing to our understanding
of the mechanisms used by S. cerevisiae to survive the chal-
lenges suffered while transiting the gut mucosa. Currently, there
are no reliable genetic engineering systems that efficiently
knockout genes in diploid, industrial yeasts. For these strains,
genetic manipulation is highly complex, although some
groundbreaking results have been recently observed (Stovicek,
Borodina, & Forster, 2015). Such systems would allow us to de-
termine the role of specific enzymes involved in neutral lipid
biosynthesis by disrupting the genes which are responsible for
their expression in industrial S. cerevisiae strains, such as those
used in this work. Also, lipid metabolism inhibitors have an-
tifungal properties (Fernandes, 1992), which would induce per
se stress in yeasts and could mask the effects caused by other
types of stressful conditions, such as digestive challenges. De-
velopment of inhibitors of specific neutral lipids, that would
discriminate the contribution of each individual lipid and would
not be toxic to yeasts, would help unravel further the specific
mechanisms of resistance to the GIT harsh environments used
by each particular strain and how that influences its probiotic
potential.
5. Conclusions
LD levels increased in S. cerevisiae strains when they were sub-
jected to simulated gastric and bile salts environments.
Plausibly, the increase in these organelle levels acted as a pro-
tective mechanism against these GIT stresses. All probiotic
strains showed an increase in LD levels when submitted to at
least one of the simulated GIT stresses, suggesting these or-
ganelles contribute to their survival and, consequently, to their
probiotic effect. Also, in the tested conditions, proliferation of
LD levels was not always observed, strengthening the idea that
the yeasts used in this study possess other defensive mecha-
nisms against stress, e.g., Sb proton-efflux protecting from low
pH levels.
Acknowledgements
We thank Professor Cláudio A. Masuda from Universidade
Federal do Rio de Janeiro, Brazil, for critically reviewing this
manuscript and helpful scientific discussions, Stefan Lamers
for manuscript editing and Jens Rietdorf (CAPES/CTDS) for tech-
nical assistance. This work was supported by grants from
Conselho Nacional de Ciência e Tecnologia (CNPq; Brasília, DF,
Brazil), Fundação de Amparo à Pesquisa do Rio de Janeiro
(FAPERJ, Rio de Janeiro, RJ, Brazil), Fundação de Amparo à
Pesquisa de Minas Gerais (FAPEMIG, Belo Horizonte, MG, Brazil)
and Fondazione RiMED (Palermo, PA, Italy). MM-L is the re-
cipient of a FAPERJ Cientistas do Nosso Estado grant. GSM is the
recipient of a CNPq Iniciação Científica fellowship. FSM is the re-
cipient of a CNPq research fellowship. BD is a Fondazione RiMED
Associate Scholar.The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of
the manuscript.
Appendix: Supplementary material
Supplementary data to this article can be found online at
doi:10.1016/j.jff.2015.12.013.
R E F E R E N C E S
Blehaut, H., Massot, J., Elmer, G. W., & Levy, R. H. (1989).
Disposition kinetics of Saccharomyces boulardii in man and rat.
Biopharmaceutics and Drug Disposition, 10, 353–364.
Bourque, S. D., & Titorenko, V. I. (2009). A quantitative
assessment of the yeast lipidome using electrospray
ionization mass spectrometry. Journal of Visualized
Experiments, 30, e1513–doi. doi:10.3791/1513.
Bozaquel-Morais, B. L., Madeira, J. B., Maya-Monteiro, C. M.,
Masuda, C. A., & Montero-Lomeli, M. (2010). A new
fluorescence-based method identifies protein phosphatases
regulating lipid droplet metabolism. PLoS ONE, 5(10),
doi:10.1371/journal.pone.0013692.
Brachmann, C. B., Davies, A., Cost, G. J., Caputo, E., Li, J., Hieter, P.,
& Boeke, J. D. (1998). Designer deletion strains derived from
Saccharomyces cerevisiae S288C: A useful set of strains and
plasmids for PCR-mediated gene disruption and other
applications. Yeast, 14, 115–132.
Cascio, V., Gittings, D., Merloni, K., Hurton, M., Laprade, D., &
Austriaco, N. (2013). S-Adenosyl-L-methionine protects the
probiotic yeast, Saccharomyces boulardii, from acid-induced cell
death. BMC Microbiology, 13(1), 35. doi:10.1186/1471-2180-13-35.
Czabany, T., Wagner, A., Zweytick, D., Lohner, K., Leitner, E.,
Ingolic, E., & Daum, G. (2008). Structural and biochemical
properties of lipid particles from the yeast Saccharomyces
cerevisiae. The Journal of Biological Chemistry, 283(25), 17065–
17074. doi:10.1074/jbc.M800401200.
Czerucka, D., Piche, T., & Rampal, P. (2007). Review article: Yeast
as probiotics – Saccharomyces boulardii. Alimentary Pharmacology
and Therapeutics, 26(6), 767–778.
Diosma, G., Romanin, D. E., Rey-Burusco, M. F., Londero, A., &
Garrote, G. L. (2014). Yeasts from kefir grains: Isolation,
identification, and probiotic characterization. World Journal of
Microbiology & Biotechnology, 30(1), 43–53. doi:10.1007/s11274-
013-1419-9.
Douradinha, B., Reis, V. C. B., Rogers, M. B., Torres, F. A. G., Evans,
J. D., & Marques, E. T. A. (2014). Novel insights in genetic
transformation of the probiotic yeast Saccharomyces boulardii.
Bioengineered, 5(1), 1–9.
Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G., Clarke,
I., Hoyle, D., Oliver, S. G., & Stateva, L. (2007). Genotypic and
physiological characterization of Saccharomyces boulardii, the
probiotic strain of Saccharomyces cerevisiae. Applied and
Environmental Microbiology, 73(8), 2458–2467.
Fei, W., Wang, H., Fu, X., Bielby, C., & Yang, H. (2009). Conditions
of endoplasmic reticulum stress stimulate lipid droplet
formation in Saccharomyces cerevisiae. The Biochemical Journal,
424(1), 61–67. doi:10.1042/BJ20090785.
Fernandes, P. B. (Ed.), (1992). New approaches for antifungal drugs.
NewYork: Springer Basel AG.
Ferraretto, L. F., Shaver, R. D., & Bertics, S. J. (2012). Effect of
dietary supplementation with live-cell yeast at two dosages
on lactation performance, ruminal fermentation, and total-
tract nutrient digestibility in dairy cows. Journal of Dairy
Science, 95(7), 4017–4028. doi:10.3168/jds.2011-5190.
199J o u rna l o f Func t i ona l F ood s 2 1 ( 2 0 1 6 ) 1 9 3 – 2 0 0
EFSA Panel on Additives and Products or Substances used in
Animal Feed (FEEDAP) (2012). Scientific Opinion on the safety
and efficacy of Actisaf Sc47 (Saccharomyces cerevisiae) as a feed
additive for rabbits for fattening and non food-producing
rabbits. EFSA Journal , 10(1), 2531. doi:10.2903/j.efsa.2012.2531.
Fietto, J. L. R., Araújo, R. S., Valadão, F. N., Fietto, L. G., Brandão, R.
L., Neves, M. J., Gomes, F. C., Nicoli, J. R., & Castro, I. M. (2004).
Molecular and physiological comparisons between
Saccharomyces cerevisiae and Saccharomyces boulardii. Canadian
Journal of Microbiology, 621, 615–621.
Garaiová, M., Zambojová, V., Šimová, Z., Griacˇ, P., & Hapala, I.
(2014). Squalene epoxidase as a target for manipulation of
squalene levels in the yeast Saccharomyces cerevisiae. FEMS
Yeast Research, 14(2), 310–323. doi:10.1111/1567-1364.12107.
Gaspar, M. L., Jesch, S. A., Viswanatha, R., Antosh, A. L., Brown, W.
J., Kohlwein, S. D., & Henry, S. A. (2008). A block in
endoplasmic reticulum-to-Golgi trafficking inhibits
phospholipid synthesis and induces neutral lipid
accumulation. The Journal of Biological Chemistry, 283(37),
25735–25751. doi:10.1074/jbc.M802685200.
Graff, S., Chaumeil, J.-C., Boy, P., Lai-Kuen, R., & Charrueau, C.
(2008). Influence of pH conditions on the viability of
Saccharomyces boulardii yeast. The Journal of General and Applied
Microbiology, 54(4), 221–227. doi:10.2323/jgam.54.221.
Hapala, I., Marza, E., & Ferreira, T. (2011). Is fat so bad?
Modulation of endoplasmic reticulum stress by lipid droplet
formation. Biology of the Cell, 103(6), 271–285. doi:10.1042/
BC20100144.
Khor, V. K., Shen, W.-J., & Kraemer, F. B. (2013). Lipid droplet
metabolism. Current Opinion in Clinical Nutrition and Metabolic
Care, 16(6), 632–637. doi:10.1016/
j.biotechadv.2011.08.021.Secreted.
Kourelis, A., Kotzamanidis, C., Litopoulou-Tzanetaki, E.,
Papaconstantinou, J., Tzanetakis, N., & Yiangou, M. (2010).
Immunostimulatory activity of potential probiotic yeast
strains in the dorsal air pouch system and the gut mucosa.
Journal of Applied Microbiology, 109(1), 260–271. doi:10.1111/
j.1365-2672.2009.04651.x.
Kurat, C. F., Natter, K., Petschnigg, J., Wolinski, H., Scheuringer, K.,
Scholz, H., Zimmermann, R., Leber, R., Zechner, R., &
Kohlwein, S. D. (2006). Obese yeast: Triglyceride lipolysis is
functionally conserved from mammals to yeast. The Journal of
Biological Chemistry, 281(1), 491–500. doi:10.1074/
jbc.M508414200.
Madeira, J. B., Masuda, C. A., Maya-Monteiro, C. M., Matos, G. S.,
Montero-Lomelí, M., & Bozaquel-Morais, B. L. (2014). TORC1
inhibition induces lipid droplet replenishment in yeast.
Molecular and Cellular Biology, 35(4), 737–746. doi:10.1128/
MCB.01314-14.
Martinez, M., Augsburger, L., Johnston, T., & Warren, W. (2002).
Applying the Biopharmaceutics Classification System to
veterinary pharmaceutical products Part I: Biopharmaceutics
and formulation considerations. Advanced Drug Delivery
Reviews, 54, 825–850.
Martins, F. S., Nardi, R. M. D., Arantes, R. M. E., Rosa, C. A.,
Neves, M. J., & Nicoli, J. R. (2005). Screening of yeasts as
probiotic based on capacities to colonize the gastrointestinal
tract and to protect against enteropathogen challenge in
mice. The Journal of General and Applied Microbiology, 51(2), 83–
92.
Martins, F. S., Veloso, L. C., Arantes, R. M. E., & Nicoli, J. R. (2009).
Effects of yeast probiotic formulation on viability, revival and
protection against infection with Salmonella enterica ssp.
enterica serovar Typhimurium in mice. Letters in Applied
Microbiology, 49(6), 738–744. doi:10.1111/j.1472-
765X.2009.02732.x.
Montañés, F. M., Pascual-Ahuir, A., & Proft, M. (2011). Repression
of ergosterol biosynthesis is essential for stress resistance
and is mediated by the Hog1 MAP kinase and the Mot3 and
Rox1 transcription factors. Molecular Microbiology, 79(4), 1008–
1023. doi:10.1111/j.1365-2958.2010.07502.x.
Palma, M. L., Zamith-Miranda, D., Martins, F. S., Bozza, F. A.,
Nimrichter, L., Montero-Lomeli, M., Marques, E. T., Jr., &
Douradinha, B. (2015). Probiotic Saccharomyces cerevisiae
strains as biotherapeutic tools: Is there room for
improvement? Applied Microbiology and Biotechnology, 99(16),
6563–6570. doi:10.1007/s00253-015-6776-x.
Pérez-Sotelo, L. S., Talavera-Rojas, M., Monroy-Salazar, H. G.,
Cuarón-Ibargüengoytia, J. A., Montes, R., Jiménez, D. O., &
Vázquez-Chagoyán, J. C. (2005). In vitro evaluation of the
binding capacity of Saccharomyces cerevisiae Sc47 to adhere to
the wall of Salmonella spp. Revista Latinoamericana De
Microbiología, 47(3–4), 70–75.
Perricone, M., Bevilacqua, A., Corbo, M. R., & Sinigaglia, M. (2014).
Technological characterization and probiotic traits of yeasts
isolated from Altamura sourdough to select promising
microorganisms as functional starter cultures for cereal-
based products. Food Microbiology, 38, 26–35. doi:10.1016/
j.fm.2013.08.006.
Saka, H. A., & Valdivia, R. (2012). Emerging roles for lipid droplets
in immunity and host-pathogen interactions. Annual Review of
Cell and Developmental Biology, 28(1), 411–437. doi:10.1146/
annurev-cellbio-092910-153958.
Sant’Ana, G. S., Paes, L. S., Paiva, A. F., Fietto, L. G., Totola, A. H.,
Trópia, M. J., Silveira-Lemos, D., Lucas, C., Fietto, J. L., Brandão,
R. L., & Castro, I. M. (2009). Protective effect of ions against
cell death induced by acid stress in Saccharomyces. FEMS
Yeast Research, 9(5), 701–712. doi:10.1111/j.1567-
1364.2009.00523.x.
Schmidt, C., Ploier, B., Koch, B., & Daum, G. (2013). Analysis of
yeast lipid droplet proteome and lipidome. Methods in Cell
Biology, 116, 15–37. doi:10.1016/B978-0-12-408051-5.00002-4.
Stovicek, V., Borodina, I., & Forster, J. (2015). CRISPR–Cas system
enables fast and simple genome editing of industrial
Saccharomyces cerevisiae strains. Metabolic Engineering
Communications, 2, 13–22. doi:10.1016/j.meteno.2015.03.001.
Van der Aa Kühle, A., Skovgaard, K., & Jespersen, L. (2005). In vitro
screening of probiotic properties of Saccharomyces cerevisiae
var. boulardii and food-borne Saccharomyces cerevisiae strains.
International Journal of Food Microbiology, 101(1), 29–39.
doi:10.1016/j.ijfoodmicro.2004.10.039.
Vieira, A. T., Teixeira, M. M., & Martins, F. S. (2013). The role of
probiotics and prebiotics in inducing gut immunity. Frontiers
in Immunology, 4, 445. doi:10.3389/fimmu.2013.00445.
Winston, F., Dollard, C., & Ricupero-Hovasse, S. L. (1995).
Construction of a set of convenient Saccharomyces cerevisiae
strains that are isogenic to S288C. Yeast, 11, 53–55.
Zanello, G., Melo, S., Berri, M., Inca, R. D., Auclair, E., & Salmon, H.
(2013). Effects of dietary yeast strains on immunoglobulin in
colostrum and milk of sows. Veterinary Immunology and
Immunopathology, 152, 20–27.
Zanghellini, J., Natter, K., Jungreuthmayer, C., Thalhammer, A.,
Kurat, C. F., Gogg-Fassolter, G., Kohlwein, S. D., & von
Grünberg, H.-H. (2008). Quantitative modeling of
triacylglycerol homeostasis in yeast – metabolic requirement
for lipolysis to promote membrane lipid synthesis and
cellular growth. The FEBS Journal, 275(22), 5552–5563.
doi:10.1111/j.1742-4658.2008.06681.x.
200 J o u rna l o f Func t i ona l F ood s 2 1 ( 2 0 1 6 ) 1 9 3 – 2 0 0
